Treatment of Preseptal Cellulitis

Diagnosis and Management

• The American College of Radiology recommends distinguishing preseptal from orbital cellulitis, as management differs dramatically and misdiagnosis can lead to permanent vision loss or life-threatening complications 1, 2, 3
• Clinical features that indicate orbital cellulitis include proptosis, impaired or painful extraocular movements, decreased visual acuity, and ophthalmoplegia 4
• Preseptal cellulitis characteristics include infection confined to eyelids and soft tissues anterior to the orbital septum, with periorbital swelling, hyperemia, and edema without globe involvement 1, 2, 3

Outpatient Treatment

• The American College of Physicians recommends outpatient treatment with high-dose oral amoxicillin-clavulanate for mild preseptal cellulitis without systemic signs, with mandatory reassessment within 24-48 hours to prevent progression to vision-threatening orbital cellulitis 4
• Criteria for outpatient management include eyelid less than 50% closed, no proptosis or visual changes, no systemic signs of infection, and reliable follow-up available 4, 5
• First-line antibiotic therapy includes high-dose amoxicillin-clavulanate, with alternative oral options including cephalexin, dicloxacillin, or clindamycin 4, 5, 6

Inpatient Treatment

• The Infectious Diseases Society of America recommends hospitalization for moderate-to-severe preseptal cellulitis, with criteria including systemic signs of infection, eyelid more than 50% closed, inability to adequately examine the eye, and poor adherence to outpatient therapy anticipated 5, 6
• Intravenous antibiotic regimens include broad-spectrum IV antibiotics covering typical Gram-positive pathogens, with options including IV amoxicillin-clavulanate, cefazolin, or ceftriaxone 4, 5, 7

MRSA Coverage

• The American College of Physicians recommends considering MRSA coverage in patients with penetrating trauma, history of injection drug use, purulent drainage, known MRSA colonization, or previous MRSA infection 5, 6
• MRSA-active antibiotics include IV options such as vancomycin, daptomycin, and linezolid, and oral options such as clindamycin, doxycycline, or trimethoprim-sulfamethoxazole 5, 6

Imaging

• The American College of Radiology recommends CT orbits with IV contrast as the most useful imaging modality when needed, to differentiate preseptal from postseptal cellulitis and orbital abscess, and to identify underlying sinusitis or complications such as superior ophthalmic vein thrombosis or cavernous sinus thrombosis 1, 2, 3
• Imaging is indicated in patients with clinical features suggesting orbital involvement, failure to improve with antibiotics within 24-48 hours, or inability to adequately examine the eye due to severe swelling 4, 1, 2, 3

Preseptal Cellulitis Diagnosis and Treatment

Critical Initial Assessment

• Red flags requiring immediate hospitalization and IV antibiotics include proptosis, impaired or painful extraocular movements, decreased visual acuity or vision changes, ophthalmoplegia, and movement restriction or diplopia, as identified by the American Academy of Ophthalmology 8
• The American Academy of Pediatrics recommends assessing visual acuity, extraocular movements, degree of eyelid swelling, presence of proptosis, and pupillary response at follow-up, with a strength of evidence level I 8

Common Predisposing Factors and Special Considerations

• Puffy eyelids with pain, erythema, and systemic signs require urgent ophthalmology referral, as indicated by the American Academy of Ophthalmology, with a moderate level of evidence 8, 9

Critical Pitfalls to Avoid

• Starting corticosteroids before ophthalmology evaluation may worsen ocular conditions due to infection, as warned by the American Academy of Ophthalmology, with a high level of evidence 8

Management Guidelines for Preseptal Cellulitis in Infants

Hospitalization Criteria

• Infants are classified as “extremes of age,” an absolute indication for inpatient management of preseptal cellulitis according to the Infectious Diseases Society of America (IDSA) recommendations. 10, 11

Initial Intravenous Antibiotic Regimen

• First‑line IV therapy for infant preseptal cellulitis includes cefazolin, which provides adequate Gram‑positive coverage. 11
• Ceftriaxone is also recommended as a first‑line IV option for broad‑spectrum coverage in this age group. 11
• Clindamycin dosing for infants is 10–13 mg/kg per dose administered intravenously every 6–8 hours, not exceeding a total of 40 mg/kg per day. 10, 11

MRSA‑Active Coverage

• Vancomycin 15 mg/kg IV every 6 hours is the preferred MRSA‑active agent for hospitalized children when MRSA is a concern. 10, 11
• When local MRSA resistance rates are below 10 %, clindamycin (10–13 mg/kg IV every 6–8 hours) can be used as an alternative MRSA‑active therapy. 10, 11

Imaging Indications and Modality

• Contrast‑enhanced CT of the orbits should be obtained in infants who exhibit any of the following: clinical signs suggesting orbital involvement (e.g., proptosis, restricted eye movements, vision changes), lack of improvement after 24–48 hours of appropriate antibiotics, severe eyelid swelling that precludes adequate ocular examination, or any suspicion of progression to post‑septal/orbital cellulitis. 12
• Contrast‑enhanced CT is the imaging modality of choice because it distinguishes pre‑septal from post‑septal cellulitis, identifies orbital abscesses, detects underlying sinusitis, and reveals complications such as superior ophthalmic vein or cavernous sinus thrombosis. 12

Treatment Duration and Transition to Oral Therapy

• The total course of antimicrobial therapy for infant preseptal cellulitis should range from 7 to 14 days, with transition to oral antibiotics once clear clinical improvement is observed (typically after 48–72 hours of IV therapy). 11

Contraindicated Antimicrobials in Infants

• Tetracycline‑class agents (e.g., doxycycline, minocycline) and trimethoprim‑sulfamethoxazole should be avoided in infants; tetracyclines are contraindicated in children younger than 8 years, and TMP‑SMX is not recommended for infants under 2 months of age. 10, 11

Imaging and Evaluation of Bilateral Preseptal Cellulitis

Risk Assessment

• Bilateral preseptal cellulitis should prompt evaluation for underlying immunocompromising conditions such as malignancy, diabetes mellitus, or immunosuppressive therapy, because these states increase the risk of systemic infection and atypical presentations. American College of Radiology recommendation. 13

Imaging Recommendations

• CT of the orbits with intravenous contrast performed emergently is advised to (1) distinguish pre‑septal from post‑septal (orbital) cellulitis, (2) identify orbital abscesses or subperiosteal collections, and (3) detect vascular complications including superior ophthalmic vein thrombosis or cavernous sinus thrombosis. American College of Radiology guideline. Evidence level not specified. 14

• MRI of the brain with high‑resolution sequences that include the cavernous sinuses should be added when any of the following are present:

Differential Diagnosis

• Bilateral periorbital swelling may represent cavernous sinus thrombosis, a condition that frequently presents with bilateral findings. Prompt imaging is essential to confirm the diagnosis. American College of Radiology guidance. Evidence level not specified. [14][13]